Myriad Genetics

IPO

Genetic Testing | Advancing Health with Myriad Genetics

Public · Salt Lake City, United States · Founded 1991 · $190.0M raised

Employees
1001–5000
Founded
1991
Business Model
B2B2C
Website
myriad.com
Total Funding
$190.0M
Last Round
$100.0M Venture RoundNov 2023
Rounds
2
Type
Public

About

Myriad Genetics is a leading genetic testing company founded in 1991, offering hereditary cancer, prenatal, oncology, and mental health genetic tests to help patients and clinicians detect, treat, and prevent disease. Its flagship MyRisk Hereditary Cancer Test screens 25 genes associated with significantly elevated cancer risk, serving patients, families, and healthcare providers worldwide.

Summary

Myriad Genetics is a Biotech company based in Salt Lake City, United States, founded in 1991. It has raised $190.0M in total across 2 rounds, most recently a $100.0M Venture Round round in Nov 2023. Investors include Bank of America, Wells Fargo and JPMorgan Chase.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundVenture RoundNov 2023
$100.0M

Sign up to see all 3 rounds

IPO through Venture Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Myriad Genetics on Indexed.vc
<a href="https://indexed.vc/companies/myriad-genetics"><img src="https://indexed.vc/api/badge/company/myriad-genetics" alt="Myriad Genetics on Indexed.vc" width="260" height="76" /></a>